» Articles » PMID: 21708191

FoxO Transcription Factors; Regulation by AKT and 14-3-3 Proteins

Overview
Specialties Biochemistry
Biophysics
Date 2011 Jun 29
PMID 21708191
Citations 364
Authors
Affiliations
Soon will be listed here.
Abstract

The forkhead box O (FoxO) transcription factor family is a key player in an evolutionary conserved pathway downstream of insulin and insulin-like growth factor receptors. The mammalian FoxO family consists of FoxO1, 3, 4 and 6, which share high similarity in their structure, function and regulation. FoxO proteins are involved in diverse cellular and physiological processes including cell proliferation, apoptosis, reactive oxygen species (ROS) response, longevity, cancer and regulation of cell cycle and metabolism. The regulation of FoxO protein function involves an intricate network of posttranslational modifications and protein-protein interactions that provide integrated cellular response to changing physiological conditions and cues. AKT was identified in early genetic and biochemical studies as a main regulator of FoxO function in diverse organisms. Though other FoxO regulatory pathways and mechanisms have been delineated since, AKT remains a key regulator of the pathway. The present review summarizes the current knowledge of FoxO regulation by AKT and 14-3-3 proteins, focusing on its mechanistic and structural aspects and discusses its crosstalk with the other FoxO regulatory mechanisms. This article is part of a Special Issue entitled: PI3K-AKT-FoxO axis in cancer and aging.

Citing Articles

Defining the Protein Phosphatase 2A (PP2A) Subcomplexes That Regulate FoxO Transcription Factor Localization.

Luperchio A, Salamango D Cells. 2025; 14(5).

PMID: 40072071 PMC: 11899004. DOI: 10.3390/cells14050342.


Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.

Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.

PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.


Pharmacodynamics of Akt drugs revealed by a kinase-modulated bioluminescent indicator.

Wu Y, Hao C, Gao C, Hageman M, Lee S, Kirkland T Nat Chem Biol. 2025; .

PMID: 39934397 DOI: 10.1038/s41589-025-01846-y.


Proline / Conformational Selection Controls 14-3-3 Binding.

Theisen F, Prestel A, Jacobsen N, Nyhegn-Eriksen O, Olsen J, Kragelund B J Am Chem Soc. 2025; 147(7):5714-5724.

PMID: 39909402 PMC: 11848828. DOI: 10.1021/jacs.4c13462.


Identification of biomarkers associated with coronary artery disease and non-alcoholic fatty liver disease by bioinformatics analysis and machine learning.

Lu C, Han M, Ma Q, Ying L, Zhang Y Sci Rep. 2025; 15(1):3557.

PMID: 39875572 PMC: 11775188. DOI: 10.1038/s41598-025-87923-7.